Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.52 USD | -1.95% | -8.03% | -18.97% |
May. 09 | The Beauty Health Company Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 09 | (SKIN) THE BEAUTY HEALTH COMPANY Forecasts Q2 Revenue Range $96M - $102M | MT |
Evolution of the average Target Price on The Beauty Health Company
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering The Beauty Health Company
Canaccord Genuity | |
TD Cowen | |
Stifel Nicolaus | |
Piper Sandler | |
Jefferies & Co. | |
William Blair & Co. | |
Raymond James | |
JPMorgan Chase | |
DA Davidson | |
BNP Paribas Exane | |
Cowen | |
Goldman Sachs | |
Benchmark Capital |
EPS Revisions
- Stock Market
- Equities
- SKIN Stock
- Consensus The Beauty Health Company